Una uses the medium of art to share her views of life at a micro and macro scale. She surveys the seldom seen-world of our cellular machinery with a perspective from outer space. Extreme precision is required to achieve the ethereal quality of the final artwork, beginning with carefully executed electron micrographs of cells magnified up to x1,000,000, obtained through a complex process of chemical fixation or cryofixation, dehydration, sectioning, staining, freeze fracturing and mounting that takes days to prepare.

She is an active Angel Investor, focusing on women-led ventures, and has a portfolio of 30 start-ups in the Bay Area. She has led public and private biotech companies as President and CEO (Diagnostics For All, Waltham Technologies, and AVANT Immunotherapeutics, now Celldex). Dr. Ryan’s academic career included Howard Hughes Investigator, Established Investigator of the American Heart Association and NIH MERIT Awardee. Her current board positions include AMRI (NASDAQ), RenovoRx, and Bell Biosystems. She is Chair of The Bay Area BioEconomy Initiative, and served on the boards of many industry organizations including BayBio, MassBio and BIO.